Abiopharma

GINKGO BIOWORKS HOLDINGS INC. (DNA) Reports the reporting period Financial Results GINKGO BIOWORKS HOLDINGS INC. (DNA) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 2672
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: $ 188,669
  • We believe that autonomous labs will replace the bench.◦The return on investment of the autonomous lab is clear for customers, with millions of square feet and tens of billions per year being spent on work happening at the lab bench◦The autonomous lab is a machine that can run 24/7 and can be seamlessly integrated into emerging AI models
  • Nebula, our autonomous lab, is showing what is possible at the bleeding edge. ◦Nebula is the world’s largest autonomous lab and in 2026 we are aiming to double its size◦Recent coverage positions Ginkgo at the frontier of scientific innovation in the scientific (Nature), trade (R&D World), mainstream (Forbes, The Washington Post), and tech press (Sequoia’s Training Data, TBPN)◦Policymakers and heads of R&D visit for our internal demonstrations. During SLAS 2026, over 500 visitors came to tour Nebula
  • Cloud Lab, Datapoints, and Solutions are our version of Starlink.◦They both create revenue and speed the development of the autonomous lab◦We are seeing traction with our Cloud Lab from partners such as ProQR and Amazon, who included us as an integrated wet lab partner on their Amazon Bio Discovery platformFull Year 2026 Outlook Management Commentary: '"We believe autonomous labs will replace the lab bench more quickly than people think," said Jason Kelly'
    • targeting to double its size this year. We see a large market that remains overwhelmingly manual today, and every experiment our Solutions, Datapoints, and Cloud Lab businesses run on Nebula generates revenue today while making the platform better for tomorrow. Ginkgo is singularly focused on leading the transition from the lab bench to autonomous research infrastructure that runs 24/7 and integrates directly with the AI models transforming drug discovery and industrial biotechnology."Recent Business Highlights & Strategic Positioning•We believe that autonomous labs will replace the bench.◦The return on investment of the autonomous lab is clear for customers, with millions of square feet and tens of billions per year being spent on work happening at the lab bench◦The autonomous lab is a machine that can run 24/7 and can be seamlessly integrated into emerging AI models•Nebula, our autonomous lab, is showing what is possible at the bleeding edge. ◦Nebula is the world’s largest autonomous lab and in 2026